20
Caverion Annual Review 2022
shares
to
be
repurchased and/or
accepted as
pledge shall
not exceed
13,500,000 shares,
which
corresponds to
approximately 9.7%
of all
the shares
in the
company. The
company may
use only
unrestricted equity
to repurchase
own shares
on the
basis of
the authorisation.
Purchase of
own
shares may be made
at a price formed
in public trading
on the date of the
repurchase or otherwise
at
a price formed on
the market. The Board of
Directors resolves on the manner in
which own shares
will be repurchased and/or accepted
as pledge. Repurchase of own shares
may be made using, inter
alia, derivatives. The
repurchase and/or
acceptance as
pledge of own shares
may be made otherwise
than in proportion
to the share ownership of the
shareholders (directed
repurchase or acceptance
as
pledge).
The authorisation cancelled the authorisation
given by the Annual General Meeting on 24 March
2021 to decide
on the repurchase and/or
acceptance as pledge of
the company’s own shares.
The
authorisation is
valid until
28 September
2023. The
Board of Directors
has not
used the authorisation
to decide on the repurchase
of the company’s own
shares during the
period.
As part
of the implementation of
the Matching Share Plan
announced on 7 February
2018, the
company has accepted
as a pledge
the shares
acquired by
those key
employees who
took a loan
from
the company. As a result, Caverion had 623,122 Caverion Corporation
shares as a pledge at the end
of the reporting period on
31 December 2022.
Share issues
The Annual General Meeting of Caverion Corporation, held on 28 March 2022, authorised the Board
of Directors to decide on
share issues in accordance
with the proposal by
the Board of Directors. The
total number
of shares
to
be
issued under
the authorisation may
not exceed
13,500,000 shares,
which corresponds to
approximately 9.7% of all
the shares
in the company.
The Board
of Directors
decides on all the conditions
of the issuance of
shares. The authorisation
concerns both the issuance
of new shares
as well as
the transfer
of treasury
shares. The issuance
of shares may
be carried out
in
deviation from the shareholders’ pre-emptive rights (directed
issue). The authorisation can be used,
e.g. in order to develop the company’s capital structure, to broaden the company’s ownership base,
to be used as payment in
corporate acquisitions or when
the company acquires assets relating
to its
business
and
as
part
of
the
company’s
incentive
programs.
The
authorisation
cancelled
the
authorisation given by the Annual General Meeting
on 24 March 2021 to decide
on the issuance of
shares. The authorisation
is valid until the end of the next
Annual General Meeting, however
no later
than 30 June 2023.
The Board of Directors
has not used the
current authorisation to decide on
share issues during
the period. The decision on
the directed share issue
without payment described under “Shares and
share capital”
was based on the
previous authorisation.
Information about shares
in Caverion Corporation
Updated lists of Caverion’s largest
shareholders and ownership
structure by sector as
per December
31, 2022
are available
on Caverion’s
website at
www.caverion.com/investors. The total combined
holdings of
the members
of the Board
of Directors,
President and CEO
and other members
of the
Group Management
Board as
per December
31, 2022
are presented
in the
notes to
the financial
statements.
Public tender offer for the shares in Caverion Corporation
A consortium of
investors led by
Bain Capital announced in
the name of
North Holdings 3
Oy on
3
November 2022
a
public
tender offer
to
the shareholders
of
Caverion. The
Board of
Directors of
Caverion, represented
by a
quorum comprising
the non-conflicted
members of
the Board
of Directors,
then unanimously decided to recommend
that the shareholders of Caverion accept the tender
offer.
More information can be found in
the stock exchange releases published on 3 November 2022 and
18 November 2022 as well
as in the tender offer document
published on 24 November
2022.
More updated information related to the tender offer and a
subsequent competing tender offer
has also been presented under
the section “Events
after the review period”.
Shares and share capital
Caverion Corporation has a single series of
shares, and each share entitles its holder
to one vote at
the general
meeting of the
company and
to an
equal dividend.
The company’s
shares have
no nominal
value.
Caverion’s articles
of
association neither
have
any
redemption or
consent clauses
nor any
provisions regarding the
procedure of changing
the articles.
The number of shares was 138,920,092 and the share capital was EUR 1,000,000 on 1 January
2022. Caverion
held 2,502,467 treasury
shares on 1
January 2022.
At the end
of the reporting
period,
the total number of
shares in Caverion was
138,920,092. Caverion held 2,447,447 treasury shares
on 31 December
2022, representing
1.76 percent
of the
total number
of shares
and voting
rights. The
number of shares outstanding
was 136,472,645 at
the end of December
2022.
The Board
of Directors
of Caverion
Corporation
decided on
a directed
share issue
without payment
for Caverion’s
Restricted Share Plan
2019–2021 reward payment, as
described in stock
exchange
release published
on 24
February 2022.
In the
directed share
issue without
payment, 55,020
Caverion
Corporation shares held by the company were on 24 February 2022 conveyed to 22 key employees
according to the terms
and conditions of the
plan. No new shares
were issued in connection
with the
plan and therefore the plan had
no diluting effect. The decision on
the directed share issue without
payment was based
on the authorisation
granted to the
Board of
Directors by the
Annual General
Meeting of Shareholders held on 24
March 2021. Prior
to the directed
share issue, Caverion held a
total of 2,502,467 treasury shares, of which 2,447,447
treasury shares remained
with the company
after the conveyance.
Information on
the incentive
plans is
presented in
the Consolidated
Financial Statements
for 2022
under Note 6.2 “Share-based
payments”.
Caverion Corporation does
not have any stock option
programmes in place.
Trading in shares
The closing price of Caverion's share was EUR 6.39 at the end of the year 2021. The
closing rate on
the
last
trading
day
of
the
review
period
on
31
December
2022 was
EUR
6.93.
The
share
price